Business
InMed Appoints Dr. Vikramaditya G. Yadav to Scientific Advisory Board
InMed Appoints Dr. Vikramaditya G. Yadav to Scientific Advisory Board Canada NewsW...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed Appoints Dr. Vikramaditya G. Yadav to Scientific Advisory Board\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, May 1, 2018\n\n\n\nTSX:IN OTCQB:IMLFF\n\n\n\nVANCOUVER, May 1, 2018 /CNW/ - InMed Pharmaceuticals Inc. (\"InMed\" or the \"Company\") (TSX:IN; OTCQB:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, announced today the addition of Dr. Vikramaditya G. Yadav to its Scientific Advisory Board. Dr. Yadav is an Assistant Professor in the Department of Chemical & Biological Engineering and School of Biomedical Engineering at the University of British Columbia (UBC), and currently serves as the Chair of the Biotechnology Division of the Chemical Institute of Canada. He has been recognized by Medicine Maker journal as one of the 100 most influential people in drug development and manufacturing.\n\n\n \n \n\n \n\"We are delighted to welcome Dr. Yadav as a formal member of the Company's Scientific Advisory Board,\" said Dr. Sazzad Hossain, Chief Scientific Officer of InMed. \"Dr. Yadav has been instrumental in advancing InMed's proprietary cannabinoid biosynthesis program. Our novel approach, which utilizes genetically engineered bacteria for the production of drugs, is currently being scaled up and optimized to manufacture therapeutically relevant cannabinoids at high yields in a commercial setting. Dr. Yadav and his team's work on strain engineering and optimization have been the building blocks for InMed's current and continued success, as well as the source of several submitted and planned patents.\"\n\nDr. Yadav received his doctoral degree in chemical engineering from the Massachusetts Institute of Technology. His graduate work focused on enzyme and microbial metabolic engineering for the synthesis of pharmaceuticals. He later conducted post-doctoral research on biophysics and bi...